These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 7262982
1. Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism. Fraser R, Beretta-Piccoli C, Brown JJ, Cumming AM, Lever AF, Mason PA, Morton JJ, Robertson JI. Hypertension; 1981; 3(3 Pt 2):I87-92. PubMed ID: 7262982 [Abstract] [Full Text] [Related]
2. Increased 18-hydroxycorticosterone responses to frusemide in essential hypertension. Semple PF, Mason PA, Fraser R. Clin Endocrinol (Oxf); 1980 May; 12(5):473-81. PubMed ID: 7428185 [Abstract] [Full Text] [Related]
3. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. Witzgall H, Lorenz R, von Werder K, Weber PC. Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312 [Abstract] [Full Text] [Related]
4. Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor. Uchida K, Kigoshi T, Iwasaki R, Morimoto S. Jpn J Med; 1989 Mar; 28(4):446-51. PubMed ID: 2554039 [Abstract] [Full Text] [Related]
5. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension. Yamamoto Y. Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295 [Abstract] [Full Text] [Related]
6. Hypermineralocorticoidism due to adrenal carcinoma: plasma corticosteroids and their response to ACTH and angiotensin II. Isles CG, MacDougall IC, Lever AF, Fraser R. Clin Endocrinol (Oxf); 1987 Feb; 26(2):239-51. PubMed ID: 2822295 [Abstract] [Full Text] [Related]
7. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production. Kater CE, Biglieri EG, Rost CR, Schambelan M, Hirai J, Chang BC, Brust N. J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240 [Abstract] [Full Text] [Related]
8. Responsiveness of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II or corticotropin in nonazotemic diabetes mellitus. Beretta-Piccoli C, Weidmann P, Fraser R. Diabetes; 1983 Jan; 32(1):1-5. PubMed ID: 6293899 [Abstract] [Full Text] [Related]
9. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels. Kem DC, Tang K, Hanson CS, Brown RD, Painton R, Weinberger MH, Hollifield JW. J Clin Endocrinol Metab; 1985 Jan; 60(1):67-73. PubMed ID: 3964794 [Abstract] [Full Text] [Related]
10. [Primary hyperaldosteronism without arterial hypertension]. Osterziel KJ, Zeier M, Raue F, Buhr H, Andrassy K, Ziegler R, Vecsei P. Dtsch Med Wochenschr; 1989 Dec 22; 114(51-52):2001-5. PubMed ID: 2689127 [Abstract] [Full Text] [Related]
11. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism. Miyamori I, Yasuhara S, Matsubara T, Okamoto S, Ikeda M, Koshida H, Morise T, Takeda Y, Takeda R, Vecsei P. Endocrinol Jpn; 1987 Dec 22; 34(6):809-19. PubMed ID: 2836182 [Abstract] [Full Text] [Related]
12. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia. Kigoshi T, Iwasaki R, Kaneko M, Nakano S, Azukizawa S, Uchida K, Morimoto S. J Clin Endocrinol Metab; 1991 Jun 22; 72(6):1200-5. PubMed ID: 1851181 [Abstract] [Full Text] [Related]
13. 10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism. Zoccali C, Usherwood T, Brown JJ, Lever AF, Robertson JI, Fraser R. J Steroid Biochem; 1983 Jul 22; 19(1A):327-31. PubMed ID: 6310234 [Abstract] [Full Text] [Related]
14. Changing pattern of the intraoperative blood pressure during endoscopic adrenalectomy in patients with Conn's syndrome. Gockel I, Heintz A, Kentner R, Werner C, Junginger T. Surg Endosc; 2005 Nov 22; 19(11):1491-7. PubMed ID: 16222471 [Abstract] [Full Text] [Related]
15. Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronism. Iwasaki R, Kigoshi T, Uchida K, Morimoto S. Acta Endocrinol (Copenh); 1989 Jul 22; 121(1):83-9. PubMed ID: 2545066 [Abstract] [Full Text] [Related]
17. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension. Lasaridis A, Brown JJ, Davies DL, Fraser R, Robertson JI, Lever AF. J Hypertens; 1984 Aug 22; 2(4):329-36. PubMed ID: 6530544 [Abstract] [Full Text] [Related]
18. Aldosterone and other mineralocorticoids in Bartter's syndrome. Saruta T, Fujimaki M, Senba S, Saito I, Konishi K. J Lab Clin Med; 1984 Jun 22; 103(6):848-53. PubMed ID: 6373989 [Abstract] [Full Text] [Related]
19. Conn´s syndrome after kidney transplantation. Javorkova M, Bystricanova A, Cirbusova M, Cvoligova M, Chrastina M, Maris J, Otavkova J, Zilinska Z. Bratisl Lek Listy; 2024 Jun 22; 125(4):258-263. PubMed ID: 38526863 [Abstract] [Full Text] [Related]